Guardian Pharmacy (GRDN) awards 4,028 restricted stock units to director

Rhea-AI Filing Summary

COSLER STEVEN D reported acquisition or exercise transactions in this Form 4 filing.

Guardian Pharmacy Services, Inc. director Steven D. Cosler received an equity grant of 4,028 shares of Class A common stock in the form of restricted stock units, awarded at no cash cost per share.

After this grant, Cosler directly holds 29,012 Class A common shares, reflecting a routine compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider COSLER STEVEN D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	4,028	$0.00	--

Holdings After Transaction: Class A Common Stock — 29,012 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant: 4,028 shares Shares owned after transaction: 29,012 shares Transaction date: May 5, 2026 +1 more

4 metrics

RSU grant 4,028 shares Restricted stock units payable in Class A common stock

Shares owned after transaction 29,012 shares Direct Class A common stock holdings after grant

Transaction date May 5, 2026 Grant date for restricted stock units

Stated grant price $0.0000 per share Indicates no cash paid by insider for award

Key Terms

restricted stock units, Class A Common Stock, Form 4

3 terms

restricted stock units financial

"Represents restricted stock units payable solely in shares of Class A common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"security_title: Class A Common Stock and shares of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COSLER STEVEN D

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/05/2026		A		4,028(1)	A	$0.00	29,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units payable solely in shares of Class A common stock of the Issuer.

	/s/ Douglas Towns, Attorney-in-Fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Guardian Pharmacy (GRDN) report for Steven D. Cosler?

Guardian Pharmacy reported that director Steven D. Cosler received an equity grant. He was awarded 4,028 restricted stock units payable in Class A common stock, increasing his direct holdings to 29,012 shares as a compensation-related transaction rather than a market trade.

How many Guardian Pharmacy (GRDN) shares were granted to Steven D. Cosler?

Steven D. Cosler was granted 4,028 restricted stock units in Guardian Pharmacy. These units are payable solely in shares of Class A common stock, providing additional equity-based compensation without any cash paid per share in this Form 4-reported transaction.

What is Steven D. Cosler’s Guardian Pharmacy (GRDN) ownership after this Form 4 grant?

Following the reported grant, Steven D. Cosler directly owns 29,012 shares of Guardian Pharmacy Class A common stock. This total reflects his position after receiving 4,028 restricted stock units as an equity award recorded in the Form 4 filing.

Was the Guardian Pharmacy (GRDN) Form 4 transaction a market purchase or sale?

The Form 4 transaction was not a market purchase or sale. It was a grant of 4,028 restricted stock units awarded at a stated price of $0.0000 per share, representing compensation rather than an open-market trade by director Steven D. Cosler.

What type of security was involved in Steven D. Cosler’s Guardian Pharmacy (GRDN) grant?

The grant involved restricted stock units that are payable solely in shares of Guardian Pharmacy’s Class A common stock. These units convert into Class A shares as specified by the award terms, adding to Cosler’s equity stake without immediate cash consideration.